John D. Mendlein
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About John D. Mendlein
John D. Mendlein was last confirmed as Chairman at Fate Therapeutics Inc (FATE) in a filing dated April 17, 2025. Fate Therapeutics Inc reported in an 8-K filed October 14, 2025 that John D. Mendlein resigned as Board, effective October 13, 2025.
“On October 10, 2025, John D. Mendlein, Ph.D., J.D. and Neelufar Mozaffarian, M.D., Ph.D., FACR each provided notice of their respective resignation from the Board, effective as of October 13, 2025.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2025-04-17
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.